COVID-19 in heart transplant recipients

Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart t...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghavi, Sepideh, Raffiei Jelodar, Hoda, Rafati, Ali, Naderi, Nasim, Mirtajaddini, Marzieh, Amin, Ahmad, Valizadeh, Leili, Omidvar, Razieh, Kamali, Monireh, Naseh, Soroush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871157/
https://www.ncbi.nlm.nih.gov/pubmed/36699553
http://dx.doi.org/10.34172/jcvtr.2022.31583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871157/
https://www.ncbi.nlm.nih.gov/pubmed/36699553
http://dx.doi.org/10.34172/jcvtr.2022.31583

Ejemplares similares